🔎 Trials Near Me

Utama › Kardiomiopati › North Carolina

Kajian klinikal Kardiomiopati di North Carolina

7 kajian untuk Kardiomiopati sedang mencari peserta di lokasi di North Carolina.

Bandar di North Carolina

Teks kajian rasmi (Bahasa Inggeris)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Charlotte
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07052903

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

  • Clinical Trial Site, Charlotte
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07358078

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  • Duke University Hospital, Durham
Mengambil pesertaFasa 2
Umur 0 hingga 16 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06080074

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Duke University Medical Center, Durham
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06563895

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

  • Duke Children's Hospital, Durham
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07674758

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • Duke University Medical Center, Durham
Mengambil pesertaFasa 3
Umur 18 hingga 90 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06128629

PKP2-ACM Natural History Study

  • Duke University, Durham
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT06644742

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.